Cas no 1400-61-9 (Nystatin)
Nystatin is an antifungal agent effective against a wide range of fungal infections. Its key advantages lie in its ability to inhibit fungal cell membrane integrity and biosynthesis, thereby preventing the growth and proliferation of sensitive fungi. Nystatin is commonly used topically or orally for dermatological and gastrointestinal applications.
Nystatin structure
Product Name:Nystatin
CAS No:1400-61-9
MF:C47H75NO17
MW:926.094916582108
MDL:MFCD27989284
CID:41317
PubChem ID:6433272
Update Time:2025-08-18
Nystatin Chemical and Physical Properties
Names and Identifiers
-
- nystatin dihydrate
- nystatin suspension cell culture tested
- Nystatin, Streptomyces noursei, Sterile, TC Grade
- Nystatin
- Nysfungin
- Nystatin (Fungicidin)
- NYSTATIN, GAMMA IRRADIATED
- biofanal
- Fungicidin Mycostatin
- Mg research grade
- MORONAL
- nilstat
- Nyotran
- Nystain
- nystan
- nystatin A1
- nystatin A2
- Nystatin Min. 4 400 units
- Nystex
- Nystop
- stamycin
- USP, ≥4,400 units
- Fungicidin
- Mycostatin
- 33-[(3-Amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-Dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid
- Fungi
- (1R,15R,16S,17S,18R,19E,21Z,25E,27E,29E,31E)-33-[(2R,3R,4R,5R,6S)-4-Amino-3,5-dihydroxy-6-methyloxan
- Mycostatin 20
- Terrastatin
- Candex Lotion
- SCHEMBL284974
- (1S,15S,16R,17R,18S)-33-{[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid
- EPA Pesticide Chemical Code 202800
- EINECS 215-749-0
- UNII-BDF1O1C72E
- KS-1373
- Candio-hermal
- (1S,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E)-33-[(3-amino-3,6-dideoxy-a-D-mannopyranosyl)oxy]-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid
- Nystatin LF (liposome)
- Moronal (antibiotic)
- Nystatinum
- NSC 150817
- AI3-26526
- EN300-19639979
- Nistatin
- Mykostatyna
- (Liposomal Nystatin)Nyotrantrade mark
- Myconystatin
- Nystatyna [Polish]
- DB00646
- Caswell No. 607B
- Nistatina [INN-Spanish]
- Mycostatin Pastilles
- Nystatyna
- AKOS016339654
- AV & NYS
- 1400-61-9
- Nystavescent
- Zydin E
- Nystatine [INN-French]
- HSDB 3138
- Nystatin [USP:INN:BAN:JAN]
- Diastatin
- Nystatin A
- Herniocid
- (4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
- Nystatinum [INN-Latin]
- Nystatine
- VQOXZBDYSJBXMA-RKEBNKJGSA-N
-
- MDL： MFCD27989284
- Inchi： 1S/C47H75NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-36(53)35(52)20-19-31(49)21-32(50)22-33(51)23-39(55)62-29(3)28(2)42(27)56/h5-6,8,10-18,27-38,40-44,46,49-54,56-58,61H,7,9,19-26,48H2,1-4H3,(H,59,60)/b6-5+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31?,32?,33?,34?,35?,36?,37?,38?,40?,41-,42+,43+,44-,46+,47+/m0/s1
- InChI Key： VQOXZBDYSJBXMA-RKEBNKJGSA-N
- SMILES： O1C2CC(C=CC=CC=CC=CCCC=CC=C[C@H](C)[C@H]([C@@H](C)[C@H](C)OC(CC(CC(CC(CCC(C(C[C@@]1(CC(C2C(=O)O)O)O)O)O)O)O)O)=O)O)O[C@@H]1[C@H]([C@H]([C@@H]([C@@H](C)O1)O)N)O |t:4,6,8,10,14,16|
Computed Properties
- Exact Mass: 925.50300
- Monoisotopic Mass: 925.5035
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 12
- Hydrogen Bond Acceptor Count: 18
- Heavy Atom Count: 65
- Rotatable Bond Count: 3
- Complexity: 1620
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 10
- Undefined Atom Stereocenter Count : 9
- Defined Bond Stereocenter Count: 6
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 320
- Surface Charge: 0
- XLogP3: -0.2
Experimental Properties
- Color/Form: Suspension
- Density: 1.31 g/cm3
- Melting Point: >155°C (dec.)
- Boiling Point: 476°Cat760mmHg
- Flash Point: 127.3°C
- Refractive Index: 1.503
- Solubility: H2O: insoluble
- PSA: 327.45000
- LogP: 1.47860
- Merck: 13,6770
- Specific Rotation: D25 -10° (glacial acetic acid); +21° (pyridine); +12° (DMF); -7° (0.1N HCl in methanol)
- Solubility: Insoluble in water.
Nystatin Security Information
- Signal Word：Warning
- Hazard Statement： H315; H319; H335
- Warning Statement： P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
- Hazardous Material transportation number：NONH for all modes of transport
- WGK Germany：3
- Hazard Category Code： 11-34
- Safety Instruction： S22-S24/25
- FLUKA BRAND F CODES：10-8-23
- RTECS：RF5950000
-
Hazardous Material Identification：
- Safety Term：S22;S24/25
- Risk Phrases：R11
- HazardClass：3
- Toxicity：LD50 i.p. in mice: ~200 mg/kg (Seneca)
- Storage Condition：-20°C, protect from light
Nystatin Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | L-KR022-1MU |
Nystatin |
1400-61-9 | ≥4,400 USP units/mg | 1MU |
￥91.0 | 2022-06-09 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | L-KR022-25MU |
Nystatin |
1400-61-9 | ≥4,400 USP units/mg | 25MU |
￥718.0 | 2022-06-09 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | L-KR022-5MU |
Nystatin |
1400-61-9 | ≥4,400 USP units/mg | 5MU |
￥184.0 | 2022-06-09 | |
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | N9150-20ML |
Nystatin |
1400-61-9 | 20ml |
￥605.71 | 2023-09-21 | ||
| TRC | N926000-10g |
Nystatin |
1400-61-9 | 10g |
$ 81.00 | 2023-09-06 | ||
| TRC | N926000-25g |
Nystatin |
1400-61-9 | 25g |
$ 155.00 | 2023-09-06 | ||
| TRC | N926000-100g |
Nystatin |
1400-61-9 | 100g |
$ 448.00 | 2023-09-06 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T1678-50 mg |
Nystatin |
1400-61-9 | 69.55% | 50mg |
￥166.00 | 2022-04-26 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T1678-100 mg |
Nystatin |
1400-61-9 | 69.55% | 100MG |
￥298.00 | 2022-04-26 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T1678-200 mg |
Nystatin |
1400-61-9 | 69.55% | 200mg |
￥428.00 | 2022-04-26 |
Nystatin Suppliers
Amadis Chemical Company Limited
Gold Member
Audited Supplier
(CAS:1400-61-9)Nystatin
Order Number:A807618
Stock Status:in Stock
Quantity:25g/100g
Purity:99%
Pricing Information Last Updated:Friday, 30 August 2024 04:47
Price ($):182.0/493.0
Email:[email protected]
Suzhou Senfeida Chemical Co., Ltd
Gold Member
Audited Supplier
(CAS:1400-61-9)Nystatin
Order Number:sfd1538
Stock Status:in Stock
Quantity:200kg
Purity:99.9%
Pricing Information Last Updated:Friday, 19 July 2024 14:32
Price ($):discuss personally
Email:[email protected]
Tiancheng Chemical (Jiangsu) Co., Ltd
Gold Member
Audited Supplier
(CAS:1400-61-9)Nystatin
Order Number:LE9708
Stock Status:in Stock
Quantity:25KG,200KG,1000KG
Purity:99%
Pricing Information Last Updated:Friday, 20 June 2025 12:02
Price ($):discuss personally
Email:[email protected]
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Gold Member
Audited Supplier
(CAS:1400-61-9)Nystatin
Order Number:LE056
Stock Status:in Stock
Quantity:5KG/1KG/25KG/100KG
Purity:99% HPLC
Pricing Information Last Updated:Thursday, 14 August 2025 14:44
Price ($):negotiated
Email:[email protected]
Nystatin Related Literature
-
Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
-
3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
-
Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
1400-61-9 (Nystatin) Related Products
- 36148-89-7(Amphotericin B methyl ester)
- 30652-87-0(Amphotericin B)
- 130767-46-3(10,29-Dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylicacid, 23-[(3-amino-3,6-dideoxy-b-D-mannopyranosyl)oxy]-1,3,5,6,27-pentahydroxy-11-(1-methylethyl)-9-oxo- (9CI))
- 1405-32-9(amphotericin A)
- 1393-12-0(12,29-Dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylicacid, 23-[(3-amino-3,6-dideoxy-b-D-mannopyranosyl)oxy]-10-ethyl-1,3,9,27-tetrahydroxy-7,11-dioxo-13-propyl-,(1R,3S,9R,10S,13R,15E,17E,19E,21E,23R,25S,26R,27S)-)
- 130433-01-1(12,31-Dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylicacid, 25-[(3-amino-3,6-dideoxy-b-D-mannopyranosyl)oxy]-1,3,4,9,29-pentahydroxy-13-(1-methylpropyl)-7,11-dioxo-(9CI))
- 1397-89-3(Amphotericin b)
- 34786-70-4(nystatin)
- 12633-72-6(Amphotericin)
- 52539-60-3(butyl (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19Z,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,3)
